EWZS:NASDAQiShares MSCI Brazil Small-Cap ETF Analysis
Data as of 2026-04-01 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
EWZS is trading at $14.86, comfortably above its 20‑day SMA (14.12) but still below the 50‑day SMA (14.74), indicating short‑term momentum while the longer‑term 200‑day SMA (13.60) remains supportive. The RSI sits at 56, suggesting neutral overbought/oversold pressure, and the MACD histogram is positive with a bullish signal line cross, reinforcing a modest upside bias. Volume is on an increasing trend, and the ETF sits near the upper end of its recent range (resistance $15.10, support $13.03), which together with a 19.86% YTD return and an "Extreme Greed" sentiment score of 77.6 points to continued buying pressure. However, the 30‑day volatility is high at 46.6% and the max drawdown of 17% signals that price swings can be sharp, especially given the fund’s exposure to Brazil’s small‑cap sector, which carries a high sector concentration risk. The low beta (0.90) and zero tracking error suggest the fund tracks its benchmark closely, while the modest expense ratio of 0.59% keeps costs in check. Overall, the ETF appears positioned for a short‑term rally but investors should remain mindful of the underlying market volatility and currency exposure.
Market Outlook
Short Term
< 1 yearKey Factors
- Bullish MACD crossover with positive histogram
- Increasing volume trend supporting price advance
- Strong YTD performance and extreme greed sentiment
Medium Term
1–3 yearsKey Factors
- Neutral RSI and price near resistance level
- High 30‑day volatility indicating potential pullbacks
- Sustained exposure to Brazil small‑cap growth prospects
Long Term
> 3 yearsKey Factors
- High sector concentration risk in Brazil small‑caps
- Moderate expense ratio with low tracking error
- Currency exposure and historical drawdown risk
Key Metrics & Analysis
Fund Metrics
Technical Analysis
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.